Fresenius forecasts 2020 profit growth driven by drug, dialysis units
Share:
(Reuters) - German healthcare group Fresenius forecast 2020 net income growth on Thursday, saying growth of its infusion drugs unit in emerging markets partially offset softer development in North America in the fourth quarter and noting strong growth of its dialysis business.Following a tumultuous 2018, when Fresenius issued several profit warnings, last year was a time of investment and stabilization for Fresenius with the group's management pointing to an improvement in growth and..